Dihydroartemisinin Targets Interleukin-1Beta to Suppress Osteoarthritis in Preclinical Models
Preclinical studies demonstrate that dihydroartemisinin directly engages interleukin-1β and attenuates NLRP3 inflammasome signaling to preserve cartilage structure in cellular and ...










